News and Conferences

Latest News

Our latest news and updates, and see where to learn more about CoreRx at Conferences, Trade Shows and Events

NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering

October 11, 2022

CoreRx Appoints Dan Dobry as Chief Strategy Officer

July 24, 2022

CoreRx Announces Successful US FDA Inspection of Clearwater Facility

CoreRx Invests in Drug Development and Manufacturing Technologies and Capabilities

June 27, 2022

CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.

June 1, 2022

CoreRx Announces Additions to Senior Scientific Staff

April 8, 2022

An Interview with… Ajay Damani – CEO, CoreRx

December 10, 2021

CoreRx Announces Successful US FDA Inspection of Clearwater Facility

November 22, 2021

CoreRx Announces New Leadership of Commercial Team

August 2, 2021

CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

July 1, 2021

CoreRx Acquires Nucleo Life Sciences

May 24, 2021

CoreRx Inc. receives approval for Schedule I controlled drug manufacture

April 30, 2021

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

August 3, 2020

CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.

March 25, 2020

JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development

February 4, 2020

Upcoming Conferences

AAPS 2022

October 16 - 19, 2022
Boston, MA

Booth# 230

CPhI Worldwide

November 1-3, 2022
Frankfurt, Germany

ICSE General Floor Booth# 90J03

Focused on Your Success

At CoreRx, we pride ourselves on continuous communication and partner engagement, innovative formulation and manufacturing solutions, and focus and dedication to meeting your drug program expectations. Tell us about your program, and we’ll tell you how we can help you succeed!